Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
IBEX Limited Schedule 13G shows American Century Investment Management, Inc., American Century Companies, Inc. and Stowers Institute for Medical Research report beneficial ownership of 680,774 shares of IBEX common stock (CUSIP G4690M101 representing 5.1% of the class). The filing lists sole voting power of 673,665 shares and sole dispositive power of 680,774. The registrants state ACIM is an investment adviser and ACIM/ACC/Stowers jointly consented to the filing.
Insights
Passive investor disclosure: 5.1% stake held via advisory structures.
The filing reports an institutional block of 680,774 shares with voting and dispositive powers attributed to American Century entities and Stowers Institute. This is a standard Schedule 13G disclosure indicating passive or qualifying institutional ownership rather than an activist intent.
Key dependencies include whether holdings change in future filings; subsequent Forms 13D or 13G amendments would alter the public ownership picture.
Filing attributes control and adviser relationships clearly.
The schedule identifies ACIM as investment adviser and notes ACC is controlled by Stowers Institute; signatures show joint consent. The disclosure clarifies voting and dispositive counts: 673,665 sole votes and 680,774 sole dispositive power.
Corporate recipients should log this for their beneficial ownership register and watch for any future amendments.
Key Figures
Shares beneficially owned:680,774 sharesPercent of class:5.1%Sole voting power:673,665 shares+1 more
4 metrics
Shares beneficially owned680,774 sharesreported on Schedule 13G
Percent of class5.1%percent of outstanding common stock as reported
Sole voting power673,665 sharessole power to vote reported by filers
CUSIPG4690M101identifier for IBEX common stock
Key Terms
Schedule 13G, beneficial ownership, sole dispositive power
3 terms
Schedule 13Gregulatory
"Item 1. | (a) | Name of issuer: IBEX Limited"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole dispositive powerregulatory
"7 | Sole Dispositive Power 680,774.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does American Century report in IBEX (IBEX)?
American Century reports beneficial ownership of 680,774 shares of IBEX common stock. The filing states this holding represents 5.1% of the class and shows 673,665 shares of sole voting power.
Who are the filers on the IBEX Schedule 13G?
The Schedule 13G is jointly filed by American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research. Signatures show each entity consented to the joint filing on May 1, 2026.
What voting and dispositive powers are reported by the filers?
The filing reports 673,665 shares as sole voting power and 680,774 shares as sole dispositive power. No shared voting or dispositive power is listed in the disclosed rows.
Which CUSIP and class of security are disclosed?
The Schedule 13G discloses IBEX common stock with CUSIP G4690M101. The filing identifies the title of the class as Common Stock and provides the issuer's principal office address in Washington, D.C.
Does the filing indicate active group or control activity?
The filing describes adviser and parent/subsidiary relationships and notes ACIM is a wholly-owned subsidiary of ACC controlled by Stowers Institute. It does not state formation of an activist group or intent to change control in this excerpt.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
IBEX Limited
(Name of Issuer)
Common Stock
(Title of Class of Securities)
G4690M101
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
G4690M101
1
Names of Reporting Persons
American Century Investment Management, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
673,665.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
680,774.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
680,774.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
G4690M101
1
Names of Reporting Persons
American Century Companies, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
673,665.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
680,774.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
680,774.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
G4690M101
1
Names of Reporting Persons
Stowers Institute for Medical Research
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
673,665.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
680,774.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
680,774.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
IBEX Limited
(b)
Address of issuer's principal executive offices:
1717 Pennsylvania Avenue NW, Suite 825, Washington, District of Columbia, 20006
Item 2.
(a)
Name of person filing:
American Century Investment Management, Inc.
American Century Companies, Inc.
Stowers Institute for Medical Research
(b)
Address or principal business office or, if none, residence:
4500 Main Street
9th Floor
Kansas City, Missouri 64111
(c)
Citizenship:
Delaware
(d)
Title of class of securities:
Common Stock
(e)
CUSIP Number(s):
G4690M101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See the response(s) to Item 9 on the attached cover page(s).
(b)
Percent of class:
See the response(s) to Item 11 on the attached cover page(s).
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s).
(ii) Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the attached cover page(s).
(iii) Sole power to dispose or to direct the disposition of:
See the response(s) to Item 7 on the attached cover page(s).
(iv) Shared power to dispose or to direct the disposition of:
See the response(s) to Item 8 on the attached cover page(s).
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
This Item identifies each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
Not applicable
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
Not applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
American Century Investment Management, Inc.
Signature:
American Century Investment Management, Inc.
Name/Title:
/s/ John Pak / Senior Vice President
Date:
05/01/2026
American Century Companies, Inc.
Signature:
American Century Companies, Inc.
Name/Title:
/s/ John Pak / Senior Vice President
Date:
05/01/2026
Stowers Institute for Medical Research
Signature:
Stowers Institute for Medical Research
Name/Title:
/s/ Joselyn Verschelden / Authorized Signer
Date:
05/01/2026
Exhibit Information
EXHIBIT
Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.
Dated this 1st day of May, 2026.
AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM")
AMERICAN CENTURY COMPANIES, INC. ("ACC")
By: __/s/ John Pak__________________
John Pak
Senior Vice President, ACIM and ACC
STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC
By: __/s/ Joselyn Verschelden_________
Joselyn Verschelden
Authorized Signer
